The correlation between the loss of Profilin1 (Pfn1) with tumor progression indicated that Pfn1 is a tumor suppressor in human carcinoma. The molecular mechanisms underlying Pfn1 tumor suppression has yet to be elucidated. In this study, we showed that Pfn1 overexpression sensitizes cancer cells to apoptosis through the typical intrinsic apoptotic pathway. Mechanistically, the increased Pfn1 expression mediated the upregulation of p53
INTRODUCTION
Tumor progression involves dynamic remodeling of actin cytoskeleton via the concerted actions of various classes of actin-binding proteins (ABPs), whose changes in expression are thought to directly contribute to oncogene-induced transformed phenotype of tumor cells [1] . Profilin1 (Pfn1) is the most common isoform of the first ABPs to be characterized, and plays an essential role in cell morphology, dendritic spine motility and immunosenescence in various kinds of mammalian cells, i.e. normal epithelial cells, neurons and T lymphocytes [2] [3] [4] . It has been identified as a tumor-related protein by the differential display screening. Pfn1 is critical for proliferation and differentiation of normal human epithelial cells [5] [6] [7] , whereas a decreased level of Pfn1 correlates with the tumorigenic state of cancer cells. Pfn1 functions as a tumor suppressor, as evidenced by the experimental manipulations of Pfn1-overexpressing in cancer cells which can suppress the phenotype of transformed cells and the formation of subcutaneous xenograft tumors in nude mice [8, 9] . However, up to now the exact function of Pfn1 in tumor initiation and development has not been completely understood.
The tumor suppressor p53, known as TP53 in human, exerts its anti-neoplastic activity primarily through the induction of apoptosis. Approximately half of cancers contain inactive mutations of p53, which are involved in the oncogenesis of human cancers [10] . Statistically, 74% of point mutations are missense mutations occurring at "hotspot" codons R273, R143, R175, R248, etc., the central DNA-binding domain of the molecule. The common mutant p53s not only abrogate the ability to transactivate downstream genes (e.g., p21 WAF1 ), but also gain a new function in conferring an increase in survival and a decrease in apoptosis. Recently, however, there has been an emerging area of research unraveling transactivationindependent induction of apoptosis by p53 [11, 12] . Accumulating experimental evidence has indicated that p53 has the capacity to engage in the apoptotic pathway directly from the cytoplasm [13] , although these studies relied on ectopic expression of p53 or overexpression of p53 mutants that lack transcriptional activity.
Microfilament actin remodeling has been a potential target for natural compounds and cancer drug development [14] . Staurosporine (STS) is a typical actin modifying drug and has been extensively utilized for the induction of apoptosis [15] [16] [17] . However, the molecular mechanism of STS-induced apoptosis remains to be determined, and it warrants further investigation on the use of STS in anticancer therapy. In our study, STS treatment was shown to induce an increase of Pfn1 protein in breast cancer cell line MDA-MB-468 and in pancreatic cancer cell line PANC-1, both harboring the same type of mutant p53 R273H . Considering these findings, we postulate that Pfn1 is responsive to STS-triggered apoptosis. In further experiments, we identified that Pfn1 overexpression could facilitate the STS-eliciting apoptosis. It was found that Pfn1 overexpression could upregulate the level of p53 R273H and restore the mutant p53 R273H function to mediate the apoptosis induced by STS. Thus, the regulation of p53 R273H by Pfn1 could be an important mechanism for Pfn1 as a tumor suppressor. STS combined with drug targeting Pfn1 could provide an insight into mutant p53 R273H as a target for cancer cell apoptosis and therapy.
MATERIALS AND METHODS

Cell Culture and Plasmid Transfection
Cell lines were maintained in either Dulbecco's modified Eagle's medium or RPMI medium 1640 (Invitrogen) supplemented with 10% fetal bovine serum, 50U of penicillin/ml, and 0.1 mg of streptomycin/ml at 37 in a 5% CO 2 humidified atmosphere. Empty vector pcDNA3.1 and plasmid encoding a full-length Pfn1 gene were previously described [18] . The two plasmids were stably transfected into breast cancer cell line MDA-MB-468 and transiently transfected into pancreatic cancer cell line PANC-1 with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The transient transfection with siRNA-p53 or its nonsense control duplex (Cell Signaling Technology) was also performed with Lipofectamine 2000 and the cells were either harvested or treated at 48h post-transfection.
Cell Viability
Cells were seeded on a 96-well plate, cultured overnight, and then treated or not with STS (Roche) from a DMSO stock (2.5mM), or with Z-VAD-CHO (80μM) from Biomol, or with combination of both drugs. The incubated cells were washed, and viability of the cells was determined by Cell Counting Kit-8 (Beyotime). Briefly, 10 l of CCK-8 solution were added into each well of the culture media for another 2h-incubation. The absorbance was measured at 450 nm using an ELISA reader (Bio-Tek, Houston, USA).
Hoechst Staining
Cells were seeded in coverslips overnight, and treated with 2.5μM STS for incubation. Washed with phosphate-buffered saline (PBS), cells were fixed with 2% formaldehyde for 10 min on ice and allowed to air dry. Cells were then staining with Hoechst 33258 for 5 min in the dark at room temperature and subsequently washed three times with PBS, 5 min each. Coverslips were mounted by glycerin and visualized under a fluorescence microscope with UV excitation at 346nm (Olympus, Tokyo, Japan).
Flow Cytometry Analysis (FACS)
Cells were collected after the treatments, washed with PBS and fixed overnight in 70% ethanol at 4 . Subsequently, they were washed again and resuspended in PBS, and then stained with 500nM propidium iodide for 15 min at 4 in the dark. The cell cycle distribution was by using flow cytometry (Becton Dickinson), and the apoptotic cells with hypodiploid DNA content were measured by quantifying the subG1 peak in the cycle pattern. For each sample, 10,000 events were recorded.
Evaluation of Mitochondrial Membrane Potential ( m)
Mitochondrial membrane potential was monitored using the fluorescent dye Rhodamine 123 (Rh123, invitrogen). Briefly, the harvested cells were treated as indicated above. Rh123 staining (2μM) was performed in the cells at 37 for 30 min in the dark. Depolarization of mitochondrial membrane potential reflected by the loss of Rh123 from mitochondria was assayed by flow cytometry.
Caspase-3 Activity Assay
Caspase-3 activity was determined using a Caspase-3 activity kit (Beyotime), which is based on the ability of caspase-3 to change acetyl-Asp-Glu-ValAsp p-nitroanilide into p-nitroaniline. Briefly, lysates were placed and incubated with the mixture composed of 10 l of cell lysates, 80 l of reaction buffer and 10 l of 2mM caspase-3 substrate at 37 for 2h, and then caspase-3 activity was quantified with a microplate spectrophotometer (Biotek) at an absorbance of 405nm.
Subcellular Fractionation
Mitochondrial isolation was performed as previously described [19] . Nuclear and cytoplasmic fractions were performed as follows: the cells were washed in cold PBS and lysed with Buffer A (10mM Hepes-KOH, PH7.9; 1.5mM MgCl 2 , 10mM KCl, 0.5mM DTT, 0.5mM PMSF, 0.6% NP40, 10 g/ml Leupeptin, 10 g/ml aprotinin); they were centrifuged at 14,000g for 5 min at 4 to collect the cytosolic supernatants. The purified nuclei were re-suspended in RIPA buffer, centrifuged at 14,000g for 10 min to collect the supernatants as the nuclear fractions.
Immunostaining and Confocal Microscopy
Cells seeded in the chamber slides with a cover were incubated with 250 nmol/L of Mito Tracker Red CMXRos (Molecular Probes) in culture medium for 30 min as suggested by the manufacturer. Cells were then washed with cold PBS (PH7.4) and fixed with 4% paraformaldehyde for 30 min, rinsed with cold PBS and permeabilized with 0.1% Triton X-100 for 30 min on the ice. The primary antibody or phalloidin (Sigma) was added before incubation at 4 overnight followed by incubating with secondary antibody IgG-FITC or IgGRhodanmin for 1h. Upon 5 min-staining with 4', 6'diamidino-2-phenylindole (DAPI) staining, cells were washed with cold PBS and mounted with mounting medium; fluorescence images were recorded by a Zeiss or Leica TCS SP5 confocal microscope and processed using Leica LAS AF Lite software.
Semi-Quantitative PCR (RT-PCR) and Real-Time PCR
The RNAs were isolated using Trizol system (Invitrogen) according to the manufacturer's instructions. RT-PCR was performed to quantify the mRNA levels of Pfn1 and p53 genes (dT) 18 -primer and MMLVRTase (Promega) were used for the first strand synthesis. Two microliter cDNA products were used for PCR amplification with primers. Real-time PCR was performed with Real-time PCR Master Mix (Promega) containing Sybgreen I and hotstart Taq DNA polymerase. The primers used are as followed: p53 
Western Blot and Immunoprecipitation Analysis
Western blot (WB) analyses were performed as previously described [18] . The proteins of interest were visualized using specific antibodies against caspase-3, caspase-9 (Cell Signaling Technology) profilin, poly-(ADP-ribose)-polymerase (PARP), p44/p42, actin (BD Pharmingen), p53, phospho-p53 ser15 (Ser15-pp53), Bax, mhsp70 (Santa Cruz), tublin, and sp1 (Upstate), respectively, followed by HRP-conjugated secondary antibodies. For immunoprecipitation, cells were lysed in buffer containing 50mM Tris-HCl PH 7.5, 150mM NaCl, 1% NP40, 5mM EDTA, 5mM EGTA, 15mM MgCl 2 , 60mM -glycerol phosphate, 0.1 mM sodium orthoranadate, 0.1mM NaF, 0.1mM benzamide, 10 g/ml aprotinin, 10 g/ml leupeptin, 1mM PMSF. Afterwards, 20 l of protein A/G agarose beads (BD, Pharmingen) were added and incubated with cell lysates and specified antibodies in 4°C. The beads were washed and subjected to SDS-PAGE and immunoblotting. The proteins were visualized via fluorography with an enhanced chemiluminescence system (Pierce).
Statistical Analysis
All the experiments were performed in triplicate, and the values were expressed as the mean±S.E.M. where appropriate. Comparisons between groups were made using one-way analysis of variance or the two-sided student's t test for unpaired samples. Statistical significance was assumed when P<0.05 was obtained.
RESULTS
Pfn1
Facilitated Staurosporine-Induced Cell Apoptosis
Our previous study showed that breast cancer cell lines presented a lower level of Pfn1 compared with several other cancer cells (data not shown). MDA-MB-468 in particular showed a relatively lower Pfn1 expression than that in normal mammary epithelium cells (Fig. 1A) . Therefore, we chose MDA-MB-468 to establish a stable cell line overexpressing Pfn1 (Pfn1-468 cells), and included an empty vector as a control (Con-468 cells). We found that STS could trigger the elevation of Pfn1 protein level either in Pfn1-468 cells or in Con-468 cells (Fig. 1B) . Thus, we chose STS as the target agent for apoptosis in this study. We compared the sensitivity of the cells to STS toxicity with or without ectopic Pfn1 expression, and CCK8 assay indicated that Pfn1-468 had dramatically reduced the viability in STS-stimulated condition compared with Con-468 cells in both time-and dose-dependent growth inhibition (Fig. 1C, D) .
To investigate the kinetics of the apoptotic cells, we examined the cell cycle distribution under STS treatment by flow cytometry. The subG1 population of Con-468 and Pfn1-468 cells with no STS treatment was assessed to be 0.2% and 1.06%, respectively. STS treatment, however, led to a dramatic increase of sub-G1 population in the two cells, and inducing more apoptosis of Pfn1-468 cells than that of Con-468 with the prolongation of culture (Fig. 1E) . To further confirm the apoptotic differences between them, the nucleus incorporation of Hoechst33258 was used to detect the early-phase apoptosis and was investigated by fluorescence microscopy. The cells in basal condition were found to exhibit uniform nuclear staining (Fig. 1F,  a, a' ), but showed apoptosis and nuclear condensation under STS treatment (Fig. 1F, b, b', c, c' ). Pfn1-468 cells displayed the nuclear apoptotic features earlier than Con-468 cells and showed a drastically exacerbated STS-induced Hoechst label. Collectively, these data showed that profilin1 enhanced the apoptotic sensitivity induced by STS.
Pfn1 Promotes the Apoptosis of Mitochondrial Pathway Triggered by STS
Mitochondria plays a critical role in the apoptotic signaling pathways [20] . To investigate whether STSinduced Pfn1-facilitated apoptosis is associated with mitochondrial stress, the activation of the mitochondrial permeability transition (MPT) was examined by FACS analysis. Our results showed that mitochondrial inner transmembrane potential ( m) was significantly decreased in Pfn1-468 cells compared to Con-468 cells following treatment with STS ( Fig. 2A, B) . In addition, STS toxicity in breast cancer cells induced the release of cytochrome C (cyto.c) from the mitochondrial intermembrane space to cytoplasm, with a more significant increase in Pfn1-468 (Fig. 2C, D) , also indicating a serious damage of mitochondria membrane. The loss of m and release of cyto.c is associated with activation of caspases and initiation of apoptotic cascades [21] . Therefore, we examined the influence of Pfn1 overexpression on caspase-3 activity in the STS-stimulated context. It was shown that STS increased Ac-DEVD-pNA sensitive caspase-3-like activity in both cells, but to a higher extent in Pfn1-468 cells (Fig. 2E) . This was also confirmed by the observation that the cleavage of poly (ADP-ribose) polymerase (PARP), which is a substrate of caspase-3 and a hallmark indicator of apoptosis, appeared earlier in Pfn1-468 cells than in Con-468 cells (Fig. 2F) . The activation of caspase-9 also confirmed the finding that Pfn1 acted as an intensifier for STS-induced apoptosis, which is classically linked to intrinsic pathway (Fig. 2G) .
To further address the significance of caspase activation in STS-induced apoptosis, we examined the effects of a caspase-3 inhibitor, Z-VAD-CHO. Pretreatment of cells with Z-VAD-CHO significantly enhanced survival in both cells exposed to STS (Fig.  2H) . Furthermore, the cleavage of PARP was also significantly inhibited by z-VAD-CHO (Fig. 2I) , indicating that caspase-3 activity had been effectively inhibited. However, Z-VAD-CHO could not completely prevent PARP cleavage and overall apoptotic cell death in Pfn1-468 cells, suggesting the existence of antagonistic effect by ectopic Pfn1 on the apoptotic inhibition.
Protein Level of p53 R273H and its Cytosolic Localization was Increased by Pfn1 Overexpression
Apoptosis progression of the eukaryotic cells is regulated by a series of intracellular apoptosis-related molecules and signaling pathways. P53, one of the most studied tumor suppressors, has been shown to play a pivotal role in various forms of apoptosis induced by cellular stress through transcriptional dependent or independent function. To elucidate the mechanism of Pfn1 promoting the apoptosis susceptibility by STS induction, we measured the level of p53 R273H gene in Con-468 and Pfn1-468 cells. Semi-quantitative RT-PCR results showed that the mRNA level of p53 in these two cells was not statistically different (Fig. 3A) . Similar results were obtained in real-time PCR analysis (Fig. 3B) . However, we found that Pfn1 overexpression led to an increase in p53 R273H protein level. The Pfn1 protein level was increased about 2.6-fold in Pfn1-468 cells as much as in Con-468 cells, and the protein level of p53 R273H increased 2.3-fold (Fig. 3C) . Furthermore, we probed the state of karyoplasm-distribution of p53 R273H in both cells by the WB analysis of cytoplasmic and nuclear fractions (Fig. 3D) . We found that ectopicPfn1 expression caused an increased location of p53 R273H in the cytoplasm independent of what is present in the nucleus, while there was a dominant localization of p53 R273H in the nuclei of Con-468 cells in basal condition. This was also clearly observed via immunofluorescence in the following experiments. Overall, our data supported that Pfn1 overexpression stabilized the p53 R273H protein in the cytoplasm.
P53
R273H is One of the Potential Factors Required for Pfn1-Facilitated Apoptosis Induced by STS
Cytoplasmic localization of endogenous wild-type or trans-activation-deficient p53 is necessary and sufficient for apoptosis [22] . To further identify whether p53 R273H with deletion of trans-activation responses to STS induced intrinsic apoptosis, we examined the level of p53 R273H and its activated form of phosphorylation in Con-468 and Pfn1-468 cells treated with STS. We identified that STS treatment resulted in the increase of phosphorylated p53 at Ser 15 (Ser15-pp53) with the prolongation of STS treatment (Fig. 4A) , but not the Ser46-pp53 (data not shown). Remarkably, an analysis of mitochondrial fractions showed that the pro-apoptotic Ser15-pp53 form was clearly detectable at the mitochondria in the presence of STS, but barely detectable in its absence in Con-468 cells. Pfn1 overexpression in Pfn1-468 resulted in its increased mitochondrial localization independent of STS stimuli, suggesting that Pfn1 might promote or facilitate p53 R273H involved intrinsic apoptosis. In addition, the substantial total p53 R273H relocalization could also be observed under STS apoptotic stimulation (Fig. 4B) , in agreement with the report by Chipuk et al. These data were further confirmed by co-immunofluorescence showing the co-localization of Ser15-pp53 with mitochondria in Con-468 and Pfn1-468 exposed to STS, especially in the basal condition of the latter one (Fig. 4C) .
To further illustrate whether upregulated p53 R273H by Pfn1 could be involved with the STS toxic effect, the role of p53 R273H in STS-induced apoptosis pathway was verified using RNA interference. The efficiency of si-p53 manipulation was determined by WB, showing the significant silencing of total p53 R273H expression in Con-468 and Pfn1-468 (Fig. 5A) . It was found that the downregulation of p53 R273H led to decreased Ser15-pp53 in both cells. And in Pfn1-468 but not Con-468, we observed a decreased Bax expression and an increased bcl-2 level following p53 R273H knockdown, whereas no change in the expression level of the nontarget gene p44/42 was observed as a negative control (Fig. 5B) . As expected, p53
R273H downregulation led to the effective suppression of STS-induced PARP cleavage, inhibiting the pro-apoptotic effect by Pfn1 overexpression (Fig. 5C) . All the results indicated that activation of the p53 R273H pathway was one of the major mechanisms for STS-induced apoptosis pertinently facilitated by Pfn1 overexpression. 
Pfn1 Functionally Associated with p53
R273H
Facilitating the Intrinsic Apoptosis by Promoting p53 R273H Localization in Cytoplasm
Pfn1 and p53 have been identified to be implicated in the same cellular apoptotic process; accordingly the potential mechanism of how Pfn1 and p53 R273H in combination produced a marked effect during the STSinduced apoptosis needed to be investigated. In light of the common concept that signaling molecules participating in a pathway are usually in a functional or physical association, we tested whether there is an interaction between Pfn1 and p53 R273H . Reciprocal coimmunoprecipitation (co-IP) experiment of Pfn1 and p53 R273H was performed with antibodies against Pfn1 or p53
R273H
, followed by WB detection with corresponding target antibodies, indicating that Pfn1 bound more p53 R273H in Pfn1-468 than that in Con-468 cells (Fig.  6A) . And the relation of Pfn1 with p53 R273H in vivo was further confirmed when the merging of the signals by confocal microscopy displayed the co-localization of Pfn1 and p53 R273H (Fig. 6B) .
Cytoplasmic localization of p53 is a prerequisite for the p53 activity to drive intrinsic apoptotic pathway [23] . Thus, we determined the p53 R273H localization following STS stimulation. WB analysis of cytoplasmic and nuclear fractions showed an increase in p53 R273H in the cytoplasm after STS treatment (Fig. 6C) , which was further verified by the findings in immunofluorescence, showing an increased dispersion of p53 R273H in cytoplasm following STS action, and existence of increased localization of p53 R273H in the cytoplasm of Pfn1-468 without STS (Fig. 6D) . Accompanied with the altered p53 R273H distribution, Pfn1 translocated from cytoplasm to the nucleus during STS treatment (Fig.  6C, E) . Thus, we hypothesize that the increased p53 R273H distribution in the cytoplasm mediated by Pfn1 overexpression could explain why Pfn1 acted as a positive regulator of p53 R273H intrinsic apoptosis.
DISCUSSION
Although previous studies have shown that Pfn1 is a negative regulator which inhibits the proliferation and migration of cancer cells [24] , the molecular mechanism is not completely understood. Normal tissue and cell development is controlled by a balance between proliferation and apoptosis, and there is compelling evidence that tumor growth is not just a result of uncontrolled proliferation but also of reduced apoptosis [25] . The balance, therefore, is crucial for determining the overall growth or regression of tumor in response to hormonal treatments, chemotherapy and radiotherapy [26, 27] . It has been reported that the general effect of Pfn1 overexpression on apoptosis of the breast cancer cell line MDA-MB-231 is induced by TNF and camptothecin [28] . In this study, we elucidated that ectopically expressed Pfn1 in MDA-MB-468 supported the apoptosis induced by STS. It is well established that the activation of the MPT is a major controlling mechanism in the apoptotic system and that overexpression of Pfn1 results in a more significant decrease of basal mitochondrial membrane potential level after the exposure of the cell line to STS. The increased cytochrome c released from the mitochondrial intermembrane space into the cytosol further stresses the more serious damage to the mitochondrial membrane in Pfn1-468 cells. In agreement with the report that the released cytochrome c facilitates the interaction between Apaf-1 and caspase-9 and results in the activation of caspase-9 and other downstream caspases, such as caspase-3 and -7 [29] , we conclude that Pfn1 promotes the activation of caspase-3 and the cleavage of PARP and caspase-9. No significant difference was observed in PARP cleavage, used as an index of middle-staged apoptosis after 4h STS treatment between Con-468 and Pfn1-468 cells, yet about 25% difference in cell viability was acquired between the two cells at those time points. We think that the index for early, middle and late apoptotic stages are time specific, and that could account for the difference between the results for two different assays. Regardless of this matter, our data support that the role of Pfn1 in sustaining its proapoptotic function is involved in the inhibiting effect of Pfn1 on cancer phenotype.
P53 plays a pivotal role in apoptosis, and the lack of a p53-regulated pathway is a common feature in a in cytoplasm and facilitate the intrinsic apoptosis. The mechanism of apoptosis involves the location of Ser15-pp53 to mitochondria, and that alters MPT, which is followed by the release of cytochrome c and results in the activation of caspase-9, caspase-3 and PARP cleavage. Pfn1 enhances the activation of this apoptotic pathway through p53 R273H upregulation and the increased cytosolic localization, which could be one of the anti-tumor mechanisms of Pfn1.
large number of tumors. Mutant p53 reactivation is reported to restore p53-transcription dependent apoptosis, hence an inefficient removal of tumor cells [30] . But an emerging area of research unravels an additional activation of p53 with no transcriptional effect in the cytoplasm, instead triggering apoptosis in the mitochondria [11, 31] . In our study we showed that an elevated Pfn1 level in MDA-MB-468 harboring a common mutant p53 R273H , one of the most common mutant forms with DNA binding activity deletion, could increase the translation of p53 R273H . Since the cytoplasmic localization of either wild type or mutant p53 is a prerequisite for its p53 intrinsic apoptosis [32] , the cytoplasmic concentration of p53 R273H increased due to Pfn1 overexpression which facilitated its transcription-independent effect. However, the p53 R273H upregulation by Pfn1 was paralleled by an increase in total p21
Waf1 and Bax level ( Supplementary Fig. 1A ). Pfn1 also induced wild type p53-independent p21 Waf1 and Bax activation. P21
Waf1 was able to be upregulated because the p53 mutants retain the ability to transactivate p21 promoter [33] . With respect to Bax, it has been reported that mutant p53 abrogating transcriptional activity could also induce its level via the pharmacological approach of PRIMA-1 [34] . We hypothesize that Pfn1 might have a similar effect as PRIMA-1 on the induction of Bax, since the Bax level was decreased when the p53 siRNA was used in Pfn1-468 cells, but not in Con-468 cells. Interestingly, ectopically expressed Pfn1 in p53-null lung cancer cell H1299 was incapable of inducing the Bax protein level ( Supplementary Fig. 1B) , suggesting that regulation of Bax by Pfn1 was likely to occur in a mutant p53-dependent way. As indicated by the report that transactivation-deficient p53 could directly activate Bax to permit an uninterrupted apoptotic pathway [32] , we detected the distribution of Bax in the presence or absence of STS. Both were found to be co-localized in the cytoplasm as well as the nucleus following STS exposure ( Supplementary Fig. 1C) . As for the ectopic Pfn1 expressing cells, it is therefore reasonable that Bax was activated in the p53 R273H transactivationindependent manner and the association with P53 R273H was strongly enhanced by Pfn1-induced p53 R273H elevation. All these results further illustrated that Pfn1 exerted cancer cell inhibition via the mechanism of mutant p53 R273H activity.
Phosphorylation of p53 at multiple sites is the main post-translational modification depending on the cell types and the extracellular stimuli. Although Ser46 phosphorylation site of p53 has been reported to enhance p53-mediated transcriptional activation of apoptotic genes [35] , no substantial change in Ser46-pp53 is evident after STS-treatment in the wt p53 R175H cell line [36] . In MDA-MB-468 harboring p53 R273H , however, we found that STS activated p53 through phosphorylation at the Ser15 residue. Other studies have reported that translocation of p53 into the mitochondria influenced the downstream events preceding changes in MMP, cytochrome c release, and caspase activation [23] ; however, the phosphorylation status of p53 targeted into mitochondria during apoptosis of cancer cells has not been determined. We observed that the Ser15-pp53 was increased in mitochondria in an STS-induced apoptosis. The results suggested that Ser15-pp53 was one of the existing forms of p53 R273H translocating to mitochondria under STS stimulation. Marchenko et al. have also reported that the p53 mitochondrial localization is a marker of the p53-dependent apoptosis in many systems and does not occur during p53-independent apoptosis [23] . Thus, it can be concluded that the mutant p53 R273H -dependent pathway can play a predominant role in the Pfn1 facilitative apoptosis in MDA-MB-468 cells. Another pancreatic cancer cell line PANC-1 which harbored the same mutant p53 R273H has also shown more significant apoptosis and an increased cytochrome c release from mitochondria into the cytoplasm when transfected with Pfn1 and treated with STS. Exogenous Pfn1 overexpression in PANC-1 cell line led to the upregulation of the p53 protein level. Ser15-pp53 (the active form) responded to the STS stimulus ( Supplementary Fig. 2 ). Our data is compatible with the conclusion that no substantial change of apoptosis was observed when overexpressing Pfn1 in p53-null cells (Supplementary Fig. 3) . However, P53
R273H knock down could protect cells from STS-induced apoptosis and death.
We observed a physical and functional link in Pfn1 and p53
R273H in vivo using the co-immunoprecipitation and immunofluorescence experiments. Our findings suggested that the Pfn1-mediated redistribution of p53 R273H and the increased p53 R273H levels in the cytoplasm could cooperate to enhance apoptotic signaling caused by the overexpression of Pfn1. The cytosolic translocation of p53 R273H induced by Pfn1 makes it easy to exert this transcriptional-independent role in the cytoplasm treated with STS. Intriguingly, STS could upregulate the Pfn1 protein level and trigger the translocation of Pfn1 from the cytoplasm to the nucleus. STS is a well-used actin disruption agent in the induction of apoptosis in diverse cellular models. The depolymerization of filament actin (F-actin) by STS could lead to the dissociation and release of actin related proteins such as Pfn1 from F-actin. The free Pfn1 could enter the nucleus and bind with p53 R273H to stabilize it. Then the stabilized p53 R273H translocates to cytoplasm and interact with cytosolic Pfn1 to facilitate the intrinsic apoptosis. Together, this data suggest a novel dynamic model that when an apoptotic need arises, Pfn1 nuclear transportation and interaction with p53 R273H could cause the p53 to shuttle from nucleus to cytoplasm. A schematic diagram was shown summarizing the mechanism of profilin1-facilitated apoptosis (Fig. 6F) . However, there are still some missed links that need to be addressed in further studies. For example, what is the specific mechanism that Pfn1 stabilizes p53 R273H , and whether p53 translocate to cytoplasm together with Pfn1? All our data supported that the failure of p53 to localize in the cytosol, rather than a defect in p53-induced transcription of pro-apoptotic genes, accounts for the loss of p53-mediated apoptosis in p53 mutant cells. Moreover, Pfn1 is suggested to be a response molecule in STS-induced death signaling, thus ectopic Pfn1 expression in cells could have a positive impact to promote STS-mediated apoptosis.
Our results provide the possibility of developing new strategies to re-establish p53 anti-neoplastic functions in tumor cells. This is the first time that Pfn1 has been observed to play an essential role in the intrinsic mitochondrial pathway of apoptosis through a mutant p53 R273H response under the death-sensing stimuli of STS. However, many questions still remain to be clarified such as the detailed mechanism on Pfn1 affecting p53 stabilization and translocation in the anterior mitochondrial apoptotic machinery, whether it is necessary for p53 R273H to be phosphorylated in order to locate to the mitochondria, and how the p53 R273H exerts its pro-apoptotic role without interacting with the Bcl2 family of permeability regulators in mitochondria. More investigations are warranted to further study the mechanism of Pfn1 mediated apoptosis in human cancers such as breast cancer and pancreatic cancer.
